Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Aurora Spine Corporation (V:ASG)

Business Focus: Medical Equipment, Supplies & Distribution (NEC)

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
Company Contact
Address: 20 HOLLY STREET, SUITE 300
Tel: N/A
IR: See website
Key People
Trent J. Northcutt
President, Chief Executive Officer, Director
Chad Clouse
Chief Financial Officer
Business Overview
Aurora Spine Corporation is a designer and manufacturer of medical devices. The Company is engaged in the development and distribution of minimally invasive, interspinous fusion systems and devices. Its product line includes implants, surgical tools and biologics. Its implants include Cervical Products, Thoraco-Lumbar Products, and SI joint products. The surgical tools include Anterior Disc Prep, Posterior Disc Prep and Compass 4D Retractor System. The biologics consist of ZIP Graft and SiLO Si-Fusion. The Company is focused on DEXA technology, which opens up treatment for osteoporotic patients. It offers DEXA-C Cervical Implants Featuring Visual Density Markers, and DEXA -L Standalone Anterior Lumbar Interbody Fusion System.
Financial Overview
For the nine months ended 30 September 2023, Aurora Spine Corp revenues decreased 7% to $10.5M. Net loss increased from $662K to $1.4M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Salaries increase of 18% to $2.2M (expense), General and Administrative increase of 26% to $1.4M (expense), Research and development increase of 20% to $810K (expense).
Employees: 13 as of Mar 31, 2013
Reporting Currency: U.S. Dollars
Enterprise value: $27.52M as of Sep 30, 2023
Annual revenue (TTM): $19.10M as of Sep 30, 2023
EBITDA (TTM): -$0.96M as of Sep 30, 2023
Net annual income (TTM): -$3.03M as of Sep 30, 2023
Free cash flow (TTM): -$1.10M as of Sep 30, 2023
Net Debt Last Fiscal Year: $4.48M as of Sep 30, 2023
Shares outstanding: 70,771,022 as of Feb 9, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization